Law firm Lowenstein Sandler announced that James Shehan, former general counsel of Novo Nordisk, will join the firm as a senior counsel in its life sciences practice and as head of the firm’s FDA regulatory practice.

Shehan previously served for over 19 years as general counsel of Novo Nordisk and most recently was of counsel at Hyman, Phelps & McNamara, an FDA regulatory law boutique firm in Washington, D.C. Early in his career, Shehan also worked as corporate counsel at Pfizer and at FDA.

Shehan brings to Lowenstein vast experience with complex regulatory issues related to drug development and life cycle management, compliance matters, internal investigations, and transactions. He has worked extensively on life sciences mergers and acquisitions as well as licensing matters. With over three decades of life sciences experience, his extensive knowledge of industry issues extends beyond drugs and biologics to medical devices, cosmetics, foods and dietary supplements. Shehan also has a particularly deep understanding of the emerging field of biosimilars.

Topics